Dana Callow - PAREXEL International Presiding Independent Director

PRXL -- USA Stock  

null 88.06  0.04  0.0454%

  Director
Mr. A. Dana Callow, Jr., is Presiding Independent Director of Parexel International Corporationrationration. Mr. Callow is the Presiding Director of the Board, Chairman of the Nominating and Corporationrationrate Governance Committee, and a member of the Audit and Finance Committee and the Human Resources Committee. Since January 1997, Mr. Callow has served as the Managing General Partner of Boston Millennia Partners, a VC firm. Since 1983, Mr. Callow has also served as a general partner of several Boston Capital Ventures limited partnerships. He is a member of the Board of Trustees of Tufts University and the Board of Overseers of Tufts University School of Medicine. He is also a member of the Board of Directors of the Tuck Center for Private Equity and Entrepreneurship at Dartmouth College and The Leukemia and Lymphoma Society.
Age: 63        
781 487-9900  http://www.parexel.com

Management Efficiency

The company has return on total asset (ROA) of 6.72 % which means that it generated profit of $6.72 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 16.93 % meaning that it created $16.93 on every $100 dollars invested by stockholders.
The company currently holds 671.5M in liabilities with Debt to Equity (D/E) ratio of 105.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PAREXEL International has Current Ratio of 1.42 which is within standard range for the sector.

Similar Executives

Showing few of many executives

DIRECTOR Since

Shlomo YanaiPerrigo Company plc
N/A
Geoffery MerszeiOrigin Agritech Limited
2016
Sanjay KhoslaZoetis
2013
Kalpana MorpariaDr Reddys Laboratories Ltd
2007
Ellen HoffingPerrigo Company plc
2008
Leo PuriDr Reddys Laboratories Ltd
2018
Theodore SamuelstoPerrigo Company plc
2017
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
Fei WangOrigin Agritech Limited
2019
Pengfei LiSinovac Biotech Ltd
2018
David GreenwayVertex Pharmaceuticals Incorpor
2017
Ravi BhoothalingamDr Reddys Laboratories Ltd
2000
Arthur RyanRegeneron Pharmaceuticals
2003
Jeffrey SmithPerrigo Company plc
2017
Bonnie BasslerRegeneron Pharmaceuticals
2016
Simon AndersonSinovac Biotech Ltd
2004
Michael JandernoaPerrigo Company plc
2007
Linda RhodesZoetis
2017
Anthony ColesRegeneron Pharmaceuticals
2017
Lloyd CarneyVertex Pharmaceuticals Incorpor
2019
Bharat DoshiDr Reddys Laboratories Ltd
2016

Entity Summary

PAREXEL International Corporationration, a biopharmaceutical services company, offer clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology solutions and services for pharmaceutical, biotechnology, and medical device industries worldwide. PAREXEL International Corp (PRXL) is traded on NASDAQ in USA and employs 18,600 people.

PAREXEL International Leadership Team

Michelle Graham, Chief Human Resource Officer, Senior Vice President
Ulf Schneider, Chief Administrative Officer, Senior Vice President
Thomas Senderovitz, Senior Vice President - Clinical Research Services
Dana Callow, Presiding Independent Director
Emma Reeve, Interim CFO, Corporate Vice President Controller
Josef Rickenbach, Founder, Chairman and CEO
Patrick Fortune, Independent Director
Eduard Holdener, Independent Director
Simon Harford, CFO, Senior Vice President
Joshua Schultz, Senior Vice President-Worldwide Head of PAREXEL Access
Gadi Saarony, Senior Vice President - Clinical Research Services
Ellen Zane, Director, Member of Compensation Committee, Member of HR Committee, CEO of Tufts Medical Center and President of Tufts Medical Center
Christian Dreger, Senior Vice President - Parexel Access and Parexel Consulting
Xavier Flinois, President - Perceptive Informatics
Douglas Batt, Sr. VP, General Counsel and Secretary
Sybrand Pretorius, Senior Vice President Chief Scientific Officer
Maykin Ho, Director
Richard Love, Independent Director
Ronald Aldridge, Sr. Director, Investor Relations
Mark Goldberg, President COO
Roland Andersson, Senior Vice President - Clinical Research Services
Christopher Lindop, Independent Director
Ingo Bank, CFO and Sr. VP
David Godwin, Senior Vice President-Global Business

Stock Performance Indicators

Current Sentiment - PRXL

PAREXEL International Investor Sentiment

Most of Macroaxis users are at this time bullish on PAREXEL International Corp. What is your perspective on investing in PAREXEL International Corp? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

GM   
Purchased over 70 shares of
a day ago
Traded for 36.96
C   
Purchased over 40 shares of
a day ago
Traded for 62.36
GM   
Purchased over 70 shares of
a day ago
Traded for 36.96
V   
Purchased few shares of
a day ago
Traded for 175.71
CRM   
Purchased a lot of shares of
a day ago
Traded for 152.04
Additionally take a look at Your Equity Center. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Search macroaxis.com